APAC Healthcare Weekly (September 14)–CSPC Pharm, TransThera, Samsung Bio, Daiichi Sankyo, Sun Pharm
CSPC Pharma’s NDA for Anbenitamab injection has been accepted in China. TransThera got trial approval for lead candidate. Samsung Bio signed $1.3B...
713 Views
Pharmaceuticals: IPM: 7% value and 2% unit decline in Jul-25
As per IQVIA, IPM saw 7.1% YoY growth in Jul-25 on a high base of 11.7% growth in Jul-24 (~11.5% YoY in Jun’25, 9% YoY in Q1FY26, and 8% in FY25)...
216 Views
HSIE Results Daily: Infosys, Dr Reddy’s Laboratories, Persistent Systems...
Infosys: Infosys delivered strong Q1FY26 performance, delivering market-leading sequential growth of 2.6% QoQ (organic ~2.2%) and 3.8% YoY in CC terms
417 Views
APAC Healthcare Weekly (July 20) – Henlius Bio, CanSino, Nippon Shinyaku, JCR, Mesoblast, Sun Pharma
Henlius Bio initiates P3 U.S. trial for cancer drug. FDA rejected Nippon Shinyaku’s new drug filing. JCR partners with Acumen to develop...
934 Views
Pharmaceuticals: IPM: 11.5% value and 5% unit growth in Jun’25
As per IQVIA, IPM saw a strong growth for Jun’25 at 11.5% YoY (vs 7% in Apr’25 and FY25, +7% YoY in Jun’24) with 5% YoY growth in units
249 Views